Practical approach to emergencies in lung transplant recipients: How we do it

Respiration

Volumn 84, Issue 2, 2012, Pages 163-175

  Schuurmans, MacÉ M ^a   Tini, Gabrielo M ^a   Zuercher, Alice ^a   Hofer, Markus ^a   Benden, Christian ^a   Boehler, Annette ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Diagnostics; Emergency; Immunosuppression; Lung transplantation; Prevention; Reflux; Respiratory infection; Respiratory symptoms; Therapeutics

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMPHOTERICIN B; CALCIUM; COLECALCIFEROL; COTRIMOXAZOLE; CYCLOSPORIN A; DILTIAZEM; DIPYRONE; DOMPERIDONE; ESOMEPRAZOLE; EVEROLIMUS; IBANDRONIC ACID; ITRACONAZOLE; MACROGOL 3350; MAGNESIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFCILLIN; OMEPRAZOLE; PANTOPRAZOLE; PARACETAMOL; PHENYTOIN; PREDNISONE; RANITIDINE; TACROLIMUS; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR; VERAPAMIL; ZOLEDRONIC ACID;

ANTIBIOTIC PROPHYLAXIS; BONE DISEASE; COUGHING; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; EMERGENCY CARE; FLUID BALANCE; GERMANY; GRAFT RECIPIENT; GRAFT REJECTION; HERPES VIRUS INFECTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; OSTEOPOROSIS; PAIN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW; RHINORRHEA; SNEEZING; SPIROMETRY; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

ANTI-INFECTIVE AGENTS; CARDIOVASCULAR DISEASES; EARLY MEDICAL INTERVENTION; EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; GASTROINTESTINAL DISEASES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MONITORING, IMMUNOLOGIC; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; SWITZERLAND;

EID: 84864091073     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000339345     Document Type: Review

References (73)

1. Lyu DM, Zamora MR: Medical complications of lung transplantation. Proc Am Thorac Soc 2009; 15;6:101-107.
2. Knoop C, Rondelet B, Dumonceaux M, Es-tenne M: Medical complications of lung transplantation (in French). Rev Pneumol Clin 2010; 67:28-49.
3. Dumonceaux M, Knoop C, Rondelet B, Es-tenne M: Complications of lung transplantation: perioperative complications, acute and chronic rejection (in French). Rev Mal Respir 2009; 26: 639-653.
4. Fuehner T, Welte T, Simon A, Gottlieb J: Complications after lung transplantation. 1. Intensive medical and pneumologic complications (in German). Dtsch Med Wochen-schr 2008; 133: 782-786.
5. Fuehner T, Welte T, Simon A, Gottlieb J: Complications after lung transplantation: gastroenterological, hematological and cardiovascular involvement (in German). Dtsch Med Wochenschr 2008; 133: 836-839.
6. Knoop C, Dumonceaux M, Rondelet B, Es-tenne M: Complications of lung transplantation (in French). Rev Mal Respir 2010; 27: 365-382.
7. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI: The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report-2011. J Heart Lung Transplant 2011; 30:1104-1122.
8. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A, et al: International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89:779-795.
9. Kumar D, Humar A (eds): The AST Handbook of Transplant Infections. Oxford, Wiley-Blackwell, 2011.
10. Cantarovich M, Brown NW, Ensom MH, Jain A, Kuypers DR, Van Gelder T, Tredger JM: Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report. Transplant Rev (Orlando) 2011; 25:65-77.
11. Hays S, Lee J, Boettger R, Golden J, Hoopes C: Lung Transplant Manual 2005. Lung Transplant Program, UCSF Medical Center. http://medicine.ucsf.edu/ education/resed/ebm/pdfs/lung-tx-manual.pdf.
12. University of Michigan Medical Center, Cardiovascular Center: Heart and Lung Transplant Guidelines, last updated 2-2006. http://www.med.umich.edu/ AnesCriticalCare/Documents/Protocol%20Manual/ Critical%20Care%20Protocol%205%20Heart%20 &%20Lung%20Section%20legal.pdf.
13. Bhorade SM, Chan KM, Levine DJ, Maurer JR, Padilla ML, Walia R: Lung Transplant Considerations for the Community Pulmo-nologist. American College of Chest Physicians, 2007. http://accpstorage.org/net-works/LungTX.pdf.
14. Sternbach GL, Varon J, Hunt SA: Emergency department presentation and care of heart and heart/lung transplant recipients. Ann Emerg Med 1992; 21: 1140-1144.
15. Playe SJ, Heilpern KL: Emergency management of infected transplant recipients: with organ transplants becoming more common and more successful, many recipients are seeking ED care for infection and rejection. Emergency Medicine News 2001; 12:22,23,51.
16. Trzeciak S, Sharer R, Piper D, Chan T, Kes-sler C, Dellinger R P, Pursell KJ: Infections and severe sepsis in solid-organ transplant patients admitted from a university-based ED. Am J Emerg Med 2004; 22: 530-533.
17. Rogers RL: The lung transplant patient in the emergency eepartment; in Adams JG, Barton ED, Collings J, DeBlieux PM, Gisondi MA, Nadel ES (eds): Emergency Medicine, ed 1. Philadelphia, Saunders Elsevier, 2008, pp 300-310.
18. Wekerle T, Klepetko W, Wisser W, Senbak-lavaci O, Artemiou O, Zuckermann A, Wolner E: Incidence and outcome of major non-pulmonary surgical procedures in lung transplant recipients. Eur J Cardiothorac Surg 1997; 12: 718-723.
19. Korom S, Boehler A, Weder W: Immunosup-pressive therapy in lung transplantation: state of the art. Eur J Cardiothorac Surg 2009; 35: 1045-1055.
20. Verleden GM, Fisher AJ, Boehler A, Estenne M: Bronchiolitis obliterans syndrome. Eur Respir Monogr 2009; 45: 197-211.
21. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, McNeil KD, Reed EF, Reinsmoen NL, Scott JP, Studer SM, Ta-zelaar HD, Wallwork JL, Westall G, Zamora MR, Zeevi A, Yousem SA: Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242.
22. Hayes D Jr: A review of bronchiolitis obliter-ans syndrome and therapeutic strategies. J Cardiothorac Surg 2011; 6:92.
23. Finkelstein SM, Scudiero A, Lindgren B, Snyder M, Hertz MI: Decision support for the t riage of lung t ransplant recipients on the basis of home-monitoring spirometry and symptom reporting. Heart Lung 2005; 34: 201-208.
24. Kugler C, Fuehner T, Dierich M, DeWall C, Haverich A, Simon A, Welte T, Gottlieb J: Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation. Transplantation 2009; 88:129-134.
25. De Vito Dabbs A, Hoffman LA, Iacono AT, Zullo TG, McCurry KR, Dauber JH: Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung 2004; 33: 372-380.
26. Krishnam MS, Suh RD, Tomasian A, Goldin JG, Lai C, Brown K, Batra P, Aberle DR: Postoperative complications of lung transplantation: radiologic findings along a time continuum. Radiographics 2007; 27: 957-974.
27. Hochhegger B, Irion KL, Marchiori E, Bello R, Moreira J, Camargo JJ: Computed tomography findings of postoperative complications in lung transplantation. J Bras Pneu-mol 2009; 35: 266-274.
28. Watkins RR, Lemonovich TL: Evaluation of infections in the lung transplant patient. Curr Opin Infect Dis 2012; 25: 193-198.
29. Ng CY, Madsen JC, Rosengard BR, Allan JS: Immunosuppression for lung transplantation. Front Biosci 2009; 14: 1627-1641.
30. de Jong PA, Vos R, Verleden GM, Vanauden-aerde BM, Verschakelen JA: Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction. Eur Radiol 2011; 21: 2466-2474.
31. Monchaud C, Marquet P: Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation. Part I. Clin Pharmacokinet 2009; 48:419-462.
32. Toivonen HJ: Anaesthesia for patients with a transplanted organ. Acta Anaesthesiol Scand 2000; 44: 812-833.
33. Knight SR, Morris PJ: Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review. Transplantation 2008; 85:1675-1685.
34. Monchaud C, Marquet P: Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation. Part II. Clin Pharmacok inet 2009; 48: 489-516.
35. Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D: Mycopheno-late, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplant Rev (Orlando) 2011; 25: 47-57.
36. Woodrow JP, Shlobin OA, Barnett SD, Burton N, Nathan SD: Comparison of bronchi-olitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29:1159-1164.
37. Krueger T, Berutto C, Aubert JD: Challenges in lung transplantation. Swiss Med Wkly 2011; 141:w13292.
38. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE: Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 174: 566-570.
39. Billaud EM, Guillemain R, Berge M, Amrein C, Lefeuvre S, Louet AL: Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients. Med Mycol 2010; 48:S52-S59.
40. Husain S, Hosseini-Mogaddham SM: Management of Infections in lung, heart-lung, and heart transplant recipients; in Kumar D, Humar A (eds): The AST Handbook of Transplant Infections. Oxford, Wiley-Black-well, 2011, pp 25-28.
41. Husain S, Zaldonis D, Kusne S, Kwak EJ, Paterson DL, McCurry KR: Variation in an-tifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006; 8:213-218.
42. Neoh CF, Snell GI, Kotsimbos T, Levvey B, Morrissey CO, Slavin MA, Stewart K, Kong DC: Antifungal prophylaxis in lung transplantation-a world-wide survey. Am J Transplant 2011; 11:361-366.
43. Benden C, Boehler A: Long-term clarithro-mycin therapy in the management of lung transplant recipients. Transplant 2009; 87: 1538-1540.
44. Chmiel C, Speich R, Hofer M, Michel D, Mertens T, Weder W, Boehler A: Ganciclo-vir/valganciclovir prophylaxis decreases cy-tomegalovirus-related events and bronchiol-itis obliterans syndrome after lung transplantation. Clin Infect Dis 2008; 46: 831-839.
45. Julian K: Evaluation and initial treatment of infectious complications among organ transplant recipients; in Kumar D, Humar A (eds): The AST Handbook of Transplant Infections. Oxford, Wiley-Blackwell, 2011, pp 11-19.
46. Manuel O: Respiratory viruses; in Kumar D, Humar A (eds): The AST Handbook of Transplant Infections. Oxford, Wiley-Blackwell, 2011, pp 55-58.
47. Garbino J, Soccal PM, Aubert JD, Rochat T, Meylan P, Thomas Y, Tapparel C, Bridevaux PO, Kaiser L: Respiratory viruses in bron-choalveolar lavage: a hospital-based cohort study in adults. Thorax 2009; 64: 399-404.
48. Bewig B, Haacke TC, Tiroke A, Bastian A, Böttcher H, Hirt SW, Rautenberg P, Haverich A: Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells. Respiration 2000; 67: 166-172.
49. Rañó A, Agustí C, Sibila O, Torres A: Pulmonary infections in non-HIV-immunocom-promised patients. Curr Opin Pulm Med 2005; 11: 213-217.
50. Ebbert JO, Limper AH: Respiratory syncy-tial virus pneumonitis in immunocompro-mised adults: clinical features and outcome. Respiration 2005; 72: 263-269.
51. Fuehner T, Dierich M, Duesberg C, DeWall C, Welte T, Haverich A, Warnecke G, Simon AR, Gottlieb J: Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections. Antivir Ther 2011; 16:733-740.
52. Karnak D, Avery RK, Gildea TR, Sahoo D, Mehta AC: Endobronchial fungal disease: an under-recognized entity. Respiration 2007; 74:88-104.
53. Morris MI: Management of selected fungal infections after transplantation; in Kumar D, Humar A (eds): The AST Handbook of Transplant Infections. Oxford, Wiley-Blackwell, 2011, pp 68-72.
54. Gerna G, Lilleri D, Rognoni V, Agozzino M, Meloni F, Oggionni T, Pellegrini C, Arbus-tini E, D'Armini AM: Preemptive therapy for systemic and pulmonary human cytomega-lovirus infection in lung transplant recipients. Am J Transplant 2009; 9: 1142-1150.
55. Snydman DR, Limaye AP, Potena L, Zamora MR: Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc 2011; 43:S1-S17.
56. Van Delden C: Timeline of infections after organ transplant; in Kumar D, Humar A, (eds): The AST Handbook of Transplant Infections. Oxford, Wiley-Blackwell, 2011, p 3.
57. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
58. Speich R, van der Bij W: Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001; 33:S58-S65.
59. Clauss HE, Bettiker RL, Samuel R, Truant AL, Jungkind D, Suh B: Infections in heart and lung transplant recipients. Clin Micro-biol Newsl 2012: 34;3: 19-25.
60. Miller CB, Malaisrie SC, Patel J, Garrity E, Vigneswaran WT, Gamelli RL: Intraabdom-inal complications after lung transplantation. J Am Coll Surg 2006; 203:653-660.
61. Gautam A: Gastrointestinal complications following transplantation. Surg Clin North Am 2006; 86:1195-1206.
62. Morton JR, Ansari N, Glanville AR, Meagh-er AP, Lord RV: Distal intestinal obstruction syndrome (DIOS) in patients with cystic fi-brosis after lung transplantation. J Gastroin-test Surg 2009; 13: 1448-1453.
63. Nicod LP: Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 2006; 3:444-449.
64. Hoekstra HJ, Hawkins K, de Boer WJ, Rot-tier K, van der Bij W: Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg 2001; 88:433-438.
65. Timrott K, Vondran FW, Jaeger MD, Gottlieb J, Klempnauer J, Becker T: Incidence and outcome of abdominal surgical interventions following lung transplantation-a single center experience. Langenbecks Arch Surg 2011; 396: 1231-1237.
66. Robertson AG, Ward C, Pearson JP, Corris PA, Dark JH, Griffin SM: Lung transplantation, gastroesophageal reflux, and fundopli-cation. Ann Thorac Surg 2010; 89:653-660.
67. Kulak CA, Borba VZ, Júnior JK, Custódio MR: Osteoporosis after transplantation. Curr Osteoporos Rep 2012; 10: 48-55.
68. Guggenheimer J, Mayher D, Eghtesad B: A survey of dental care protocols among US organ transplant centers. Clin Transplant 2005; 19: 15-18.
69. Ziebolz D, Hraský V, Goralczyk A, Horneck-er E, Obed A, Mausberg RF: Dental care and oral health in solid organ transplant recipients: a single center cross-sectional study and survey of German transplant centers. Transpl Int 2011; 24:1179-1188.
70. Gohh RY, Warren G: The preoperative evaluation of the transplanted patient for non-transplant surgery. Surg Clin North Am 2006; 86: 1147-1166.
71. De Vito Dabbs A, Song MK: Risk profile for cardiovascular morbidity and mortality after lung transplantation. Nurs Clin North Am 2008; 43: 37-53.
72. Boscoe M: Anesthesia for patients with transplanted lungs and heart and lungs. Int Anesthesiol Clin 1995; 33:21-44.
73. Haddow GR: Anaesthesia for patients after lung transplantation. Can J Anaesth 1997; 44: 182-197.